Stocktoria

Cardiff Oncology, Inc. CRDF

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2004-07-27 · LEI

Cardiff Oncology, Inc. statistics & valuation

Market cap$85.5M
P / B1.9×
Net margin-7732.0%
Return on equity-101.0%
FCF margin-6402.5%
Return on capital-107.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-10287.70% -4928.10% -4351.10% -6709.70% -5275.10% -7880.50% -10026.90% -8492.00% -6651.70% -7732.00% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-10534.90% -5064.40% -4507.60% -6817.80% -5214.80% -8037.60% -10337.30% -9305.70% -7123.10% -8256.30% 2016201720182019202020212022202320242025
Return on equity (%)
-198.30% -382.80% -163.20% -224.50% -15.10% -20.10% -36.40% -59.40% -54.80% -101.00% 2016201720182019202020212022202320242025
Shares outstanding
30.7M 733217 3.8M 8.6M 36.8M 42.0M 44.7M 44.7M 66.5M 68.3M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-89.20% -202.70% -116.10% -125.40% -14.30% -18.90% -33.30% -50.80% -46.70% -74.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-8361.50% -4626.40% -3490.20% -5451.10% -4515.30% -6474.90% -9022.30% -6448.60% -5530.50% -6402.50% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.37 -$51.76 -$8.26 -$1.08 -$0.73 -$0.89 -$0.93 -$0.95 -$0.69 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-8256.3%-7123.1%-9305.7%-10337.3%-8037.6%-5214.8%-6817.8%-4507.6%-5064.4%-10534.9%
Net margin-7732.0%-6651.7%-8492.0%-10026.9%-7880.5%-5275.1%-6709.7%-4351.1%-4928.1%-10287.7%
FCF margin-6402.5%-5530.5%-6448.6%-9022.3%-6474.9%-4515.3%-5451.1%-3490.2%-4626.4%-8361.5%
Return on assets-74.1%-46.7%-50.8%-33.3%-18.9%-14.3%-125.4%-116.1%-202.7%-89.2%
Return on equity-101.0%-54.8%-59.4%-36.4%-20.1%-15.1%-224.5%-163.2%-382.8%-198.3%
Current ratio3.677.087.4114.2522.2821.792.374.372.405.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.